Skip to content

Latest

Jean Coutu reports uptick in sales, earnings

Despite the deflationary impact of new generic drugs, Jean Coutu Group posted a slight revenue and same-store sales gains for its fiscal 2014 first quarter, while adjusted earnings were in line with analysts’ forecast.

Orexo cleared to launch Zubsolv

Orexo U.S. Inc. has received approval from the Food and Drug Administration for Zubsolv sublingual tablets, indicated for the maintenance treatment of opioid dependence.

Martindale becomes Rite Aid president

Ken Martindale, who has been a proponent of change and innovation at Rite Aid Corp., has been named the company’s president. The 53-year-old Martindale had been senior executive vice president and, since 2010, chief operating officer, a post he retains.

In-store clinics will see surge in demand

Demand from newly insured patients under the Affordable Care Act (ACA) will double the number of retail clinics in the next three years, management consulting firm Accenture has projected. Walk-in clinics will drive $800 million in annual cost savings by 2015 and add capacity for 10.

Rite Aid unveils wellness65+

Rite Aid has extended its wellness+ customer loyalty program with the launch of wellness65+. “Attracting new senior customers represents a key growth opportunity for Rite Aid because seniors tend to be our best pharmacy patients,” president and chief operating officer Ken Martindale says.